Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Assets (2018 - 2025)

Historic Assets for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to $287.8 million.

  • Neurogene's Assets rose 7537.9% to $287.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $287.8 million, marking a year-over-year increase of 7537.9%. This contributed to the annual value of $335.7 million for FY2024, which is 5084.04% up from last year.
  • As of Q3 2025, Neurogene's Assets stood at $287.8 million, which was up 7537.9% from $297.3 million recorded in Q2 2025.
  • In the past 5 years, Neurogene's Assets ranged from a high of $335.7 million in Q4 2024 and a low of $89.6 million during Q3 2023
  • Its 3-year average for Assets is $207.3 million, with a median of $195.4 million in 2024.
  • Data for Neurogene's Assets shows a peak YoY increase of 9840.54% (in 2024) and a maximum YoY decrease of 5084.04% (in 2024) over the last 5 years.
  • Neurogene's Assets (Quarter) stood at $222.6 million in 2023, then surged by 50.84% to $335.7 million in 2024, then fell by 14.27% to $287.8 million in 2025.
  • Its Assets stands at $287.8 million for Q3 2025, versus $297.3 million for Q2 2025 and $315.3 million for Q1 2025.